Physician profile
Daniel A Graf
NPI 1255591434
$12,830.35
in general payments reported to CMS, 2019-2025
12 companies · $5,457 in 2025
The $5,457 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2022: $295 · 2023: $912 · 2024: $5,726 · 2025: $5,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Food and Beverage: $4,161 · Travel and Lodging: $908 · Consulting Fee: $675 · Education: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Food and Beverage | $4,161.02 |
| Travel and Lodging | $907.51 |
| Consulting Fee | $675.00 |
| Education | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $8,337.17 | 2022-2025 | Nayzilam, Briviact, Fintepla |
| Livanova USA, INC. | $2,130.90 | 2023-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Sk Life Science, INC. | $581.54 | 2022-2025 | Xcopri |
| Neurelis, INC. | $488.63 | 2023-2025 | Valtoco |
| Eisai INC. | $446.53 | 2019-2025 | |
| Neuropace, INC. | $300.15 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $124.68 | 2023 | Austedo |
| Insightec,INC | $119.78 | 2024 | Exablate |
| Sunovion Pharmaceuticals INC. | $98.87 | 2019 | |
| Jazz Pharmaceuticals INC. | $77.16 | 2025 | |
| Medtronic, INC. | $73.14 | 2022 | |
| Ceribell, INC. | $51.80 | 2025 | Pocket Eeg Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Graf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.